Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

13.25
Delayed Data
As of Apr 29
 -0.16 / -1.19%
Today’s Change
8.90
Today|||52-Week Range
30.23
-15.77%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close13.41
Today’s open13.31
Day’s range13.12 - 13.68
Volume204,483
Average volume (3 months)436,741
Market cap$524.6M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+34.88%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.64-4.97%
RVNCRevance Therapeutics...-0.41-2.18%
TGTXTG Therapeutics Inc-0.31-3.29%
SGYPSynergy Pharmaceutic...-0.16-4.85%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers

Search for Jobs